SOLESENCE, INC. — Director's Dealing 2018

Mar 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2018-03-26

Reporting Person: ESCOBAR JAIME (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-26	Employee Stock Option (right to buy)	$.44	A	36000	Acquired	2028-03-26	Common Stock (36000)	Direct

Footnotes

F1: Vests in three equal annual installments commencing on March 26, 2019.